A case series on post-covid deadly fungal infection: mucormycosis
DOI:
https://doi.org/10.18203/issn.2454-5929.ijohns20213287Keywords:
SARS-CoV-2, Mucormycosis, Steroids, Diabetes mellitusAbstract
The prevailing pandemic situation by SARS-CoV-2 infection is not only worrisome by the disease per se but also for the accompanying opportunistic infection are in the rise especially in diabetic patients. We presented a case series of post-covid rhino orbital cerebral mucormycosis infection in diabetic patients resulting in high morbidity. The need to present this was to emphasis on the timely surgical and medical intervention needed to reduce morbidity and mortality by the infection. The study highlighted the importance of surgical intervention in the deadly infection.
References
Spellberg B, Walsh TJ, Kontoyiannis DP, Edwards J, Ibrahim AS. Recent advances in the management of mucormycosis from bench to bedside. Clin Infect Dis. 2009;48(12):1743-51.
Spellberg B, Edwards J, Ibrahim A. Novel Perspectives on mucormycosis: pathophysiology, presentation,and management. Clin Microbiol Rev. 2005;18(3):556-69.
Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis. 2012;54(1):23-34.
McNulty JS. Rhinocerebral mucormycosis predisposing factors. Laryngoscope. 1982;92:1140-3.
Sharma S, Grover M, Bhargava S, Samdani S, Kataria T. Post coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum. J Laryngol Otol. 2021;135(5):442-7.
